ALT vs DAL · rev $20.0K vs P/E 12, rev $61.64B
Altimmune Inc (ALT) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
ALT currently screens at market cap $527.0M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the ALT and DAL stock pages for the full models.
Not investment advice.